{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T19:40:08Z","timestamp":1751053208539,"version":"3.41.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1997,7,1]],"date-time":"1997-07-01T00:00:00Z","timestamp":867715200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[1997,7,1]],"date-time":"1997-07-01T00:00:00Z","timestamp":867715200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drugs Ther"],"published-print":{"date-parts":[[1997,7]]},"DOI":"10.1023\/a:1007749522688","type":"journal-article","created":{"date-parts":[[2002,12,22]],"date-time":"2002-12-22T11:08:11Z","timestamp":1040555291000},"page":"459-463","source":"Crossref","is-referenced-by-count":3,"title":["Problems in the Evaluation of Antihypertensive Therapy Using the Trough\/Peak Ratio"],"prefix":"10.1007","volume":"11","author":[{"given":"Fernando A.","family":"Prattichizzo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio","family":"Galetta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ignazio","family":"Simonetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"145423_CR1","volume-title":"Proposed Guidelines for the Clinical Evaluation of Anti-hypertensive Drugs","author":"FoodDrug Administration.","year":"1988","unstructured":"Food and Drug Administration. Proposed Guidelines for the Clinical Evaluation of Anti-hypertensive Drugs. Rockville, MD: Division of Cardio-Renal Drug Products, US Department of Health and Human Services, 1988."},{"key":"145423_CR2","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/ajh\/3.2.151","volume":"3","author":"M Rose","year":"1990","unstructured":"Rose M, McMahon FG. Some problems with antihypertensive drug studies in the context of the new guidelines. Am J Hypertens 1990;3:151\u2013155.","journal-title":"Am J Hypertens"},{"issue":"Suppl8","key":"145423_CR3","first-page":"S17","volume":"12","author":"RJ. Lipicky","year":"1994","unstructured":"Lipicky RJ. Trough:peak ratio: The rationale behind the United States Food and Drug Administration recommendations. J Hypertens 1994;12(Suppl 8):S17\u2013S19.","journal-title":"J Hypertens"},{"key":"145423_CR4","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/00004872-199503000-00001","volume":"13","author":"HL Elliott","year":"1995","unstructured":"Elliott HL, Meredith PA: Trough:peak ratio: Clinically useful or practically irrelevant? J Hypertens 1995;13:279\u2013283.","journal-title":"J Hypertens"},{"key":"145423_CR5","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/00004872-199104000-00008","volume":"9","author":"E Mutti","year":"1991","unstructured":"Mutti E, Trazzi S, Omboni S, Parati G, Mancia G: Effect of placebo on 24-h non-invasive blood pressure. J Hypertens 1991;9:361\u2013364.","journal-title":"J Hypertens"},{"key":"145423_CR6","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1097\/00004872-199310000-00018","volume":"11","author":"W Gerin","year":"1993","unstructured":"Gerin W, Rosofsky M, Pieper C, Pickering TG: A test of reproducibility of blood pressure and heart rate variability using a controlled ambulatory procedure. J Hypertens 1993;11:1127\u20131131.","journal-title":"J Hypertens"},{"key":"145423_CR7","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1097\/00004872-199210120-00014","volume":"10","author":"G Mancia","year":"1992","unstructured":"Mancia G, Omboni S, Parati G, Trazzi S, Mutti E. Limited reproducibility of hourly blood pressure values obtained by ambulatory blood pressure monitoring: Implications for studies on antihypertensive drugs. J Hypertens 1992;10:1531\u20131535.","journal-title":"J Hypertens"},{"key":"145423_CR8","first-page":"469","volume":"12","author":"G Mancia","year":"1994","unstructured":"Mancia G, Ulian L, Parati G, Trazzi S. Increase in blood pressure reproducibility by repeated semi-automatic blood pressure measurement in the clinic environment. J Hypertens 1994;12:469\u2013473.","journal-title":"J Hypertens"},{"key":"145423_CR9","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1097\/00004872-199510000-00005","volume":"13","author":"S Omboni","year":"1995","unstructured":"Omboni S, Parati G, Zanchetti A, Mancia G. Calculation of trough-to-peak ratio of antihypertensive treatment from ambulatory blood pressure: Methodological aspects. J Hypertens 1995;13:1105\u20131112.","journal-title":"J Hypertens"},{"key":"145423_CR10","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/0895-7061(94)00243-5","volume":"8","author":"MG. Myers","year":"1995","unstructured":"Myers MG. Trough-to-peak ratio and 24-hour blood pressure control. Methodological issues. Am J Hypertens 1995;8:214\u2013219.","journal-title":"Am J Hypertens"},{"issue":"Suppl8","key":"145423_CR11","first-page":"S21","volume":"12","author":"J Menard","year":"1994","unstructured":"Menard J, Chatellier G, Day M, Vaur L. Self-measurement of blood pressure at home to evaluate drug effects by the trough:peak ratio. J Hypertens 1994;12(Suppl 8):S21\u2013S25.","journal-title":"J Hypertens"},{"key":"145423_CR12","first-page":"S79","volume":"Suppl8","author":"PA Meredith","year":"1994","unstructured":"Meredith PA, Elliott H. Antihypertensive treatment and trough:peak ratio: General considerations. J Hypertens 1994(Suppl 8):S79\u2013S83.","journal-title":"J Hypertens"},{"key":"145423_CR13","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1097\/00004872-199012000-00003","volume":"8","author":"PA Meredith","year":"1990","unstructured":"Meredith PA, Donnelly R, Elliott HL, Howie CA, Reid TL. Prediction of the antihypertensive response to enalapril. J Hypertens 1990;8:1085\u20131090.","journal-title":"J Hypertens"},{"key":"145423_CR14","first-page":"3049","volume-title":"Hypertension: Pathophysiology, Diagnosis, and Management","author":"J M\u00e9nard","year":"1995","unstructured":"M\u00e9nard J, Bellet M, Brunner HR: Clinical development of antihypertensive drugs. In: Laragh JH, Brenner BM, eds. Hypertension: Pathophysiology, Diagnosis, and Management. New York: Raven Press, 1995:3049\u20133063."},{"key":"145423_CR15","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1161\/01.CIR.59.5.1056","volume":"59","author":"MT Olivari","year":"1979","unstructured":"Olivari MT, Bartorelli C, Polese A, Fiorentini C, Moruzzi P, Guazzi MD. Treatment of hypertension with nifedipine, a calcium antagonist agent. Circulation 1979;59:1056\u20131062.","journal-title":"Circulation"},{"issue":"Suppl1","key":"145423_CR16","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1097\/00004872-199303001-00004","volume":"11","author":"PA Meredith","year":"1993","unstructured":"Meredith PA, Reid JL. Differences between calcium antagonists: Duration of action and trough to peak ratio. J Hypertens 1993;11(Suppl 1):S21\u2013S26.","journal-title":"J Hypertens"},{"issue":"SupplIII","key":"145423_CR17","first-page":"7","volume":"17","author":"PA Meredith","year":"1994","unstructured":"Meredith PA, Elliott HI. Amlodipine\u2014Does the effect-time profile directly reflect the concentration-time profile throughout a 24-hour period? Clin Cardiol 1994;17(Suppl III):7\u201311.","journal-title":"Clin Cardiol"},{"issue":"Suppl8","key":"145423_CR18","first-page":"S97","volume":"12","author":"A. Zanchetti","year":"1994","unstructured":"Zanchetti A. Trough:peak ratio of the blood pressure response to dihydropyridine calcium antagonists. J Hypertens 1994;12(Suppl 8):S97\u2013S106.","journal-title":"J Hypertens"},{"issue":"Suppl5","key":"145423_CR19","first-page":"S334","volume":"11","author":"A Zanchetti","year":"1993","unstructured":"Zanchetti A, Bianchi L, Amigoni S, Omboni S, Villani A, Ravogli A. Antihypertensive effects of nifedipine gastrointestinal therapeutics system on clinic and ambulatory blood pressure in essential hypertensives. J Hypertens 1993;11(Suppl 5):S334\u2013S335.","journal-title":"J Hypertens"},{"unstructured":"Strasser T, Wilhelmsen L. W.H.O. Regional Publications European Series No. 47, 1993.","key":"145423_CR20"},{"key":"145423_CR21","first-page":"99","volume":"3","author":"FA Prattichizzo","year":"1995","unstructured":"Prattichizzo FA, Galetta F. How common is \u201cwhite coat normotension\u201d? Int Med\u2014Clin Lab 1995;3:99\u2013102.","journal-title":"Int Med\u2014Clin Lab"},{"key":"145423_CR22","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1177\/000331979604700704","volume":"47","author":"FA Prattichizzo","year":"1996","unstructured":"Prattichizzo FA, Galetta F. White coat normotension and blood pressure variability. Angiology 1996;47:663\u2013668.","journal-title":"Angiology"},{"issue":"Suppl8","key":"145423_CR23","first-page":"S35","volume":"12","author":"G Mancia","year":"1994","unstructured":"Mancia G, Frattola A, Groppelli A, et al. Blood pressure reduction and end-organ damage in hypertension. J Hypertens 1994;12(Suppl 8):S35\u2013S42.","journal-title":"J Hypertens"},{"key":"145423_CR24","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1097\/00004872-199310000-00019","volume":"11","author":"A Frattola","year":"1993","unstructured":"Frattola A, Parati G, Cuspidi C, Albini F, Mancia G. Prognostic value of 24-hour blood pressure variability. J Hypertens 1993;11:1133\u20131137.","journal-title":"J Hypertens"},{"key":"145423_CR25","first-page":"587","volume":"41","author":"FA Prattichizzo","year":"1993","unstructured":"Prattichizzo FA, Galetta F. Effect of atenolol and benazepril on 24 hour blood pressure variability. Minerva Cardioangiol 1993;41:587\u2013590.","journal-title":"Minerva Cardioangiol"},{"issue":"Suppl6B","key":"145423_CR26","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1016\/0002-9343(89)90096-X","volume":"87","author":"G Mancia","year":"1989","unstructured":"Mancia G, Casadei R, Mutti E, Trazzi S, Parati G. Ambulatory blood pressure monitoring in the evaluation of antihypertensive treatment. Am J Med 1989;87(Suppl 6B):S64\u2013S69.","journal-title":"Am J Med"},{"issue":"Suppl8","key":"145423_CR27","first-page":"S59","volume":"9","author":"R. Lipicky","year":"1991","unstructured":"Lipicky R. The United States Food and Drug Administration guidelines on ambulatory blood pressure monitoring. J Hypertens 1991;9(Suppl 8):S59.","journal-title":"J Hypertens"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1007749522688.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1007749522688\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1007749522688.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T19:09:48Z","timestamp":1751051388000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1007749522688"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,7]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1997,7]]}},"alternative-id":["145423"],"URL":"https:\/\/doi.org\/10.1023\/a:1007749522688","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"type":"print","value":"0920-3206"},{"type":"electronic","value":"1573-7241"}],"subject":[],"published":{"date-parts":[[1997,7]]}}}